Skip to main content
Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
42.41
-0.23 (-0.54%)
Aug 14, 2025, 1:57 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Treatment of Central Nervous System Diseases
661.82M
Log In
Log In
Log In
Log In
Upgrade
Treatment of Central Nervous System Diseases Growth
8.94%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
661.82M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
8.94%
Log In
Log In
Log In
Log In
Upgrade